1. Home
  2. CCEL vs LOAN Comparison

CCEL vs LOAN Comparison

Compare CCEL & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$5.40

Market Cap

41.8M

Sector

Health Care

ML Signal

N/A

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

N/A

Current Price

$3.25

Market Cap

38.8M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEL
LOAN
Founded
1989
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
41.8M
38.8M
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
CCEL
LOAN
Price
$5.40
$3.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.6K
★ 23.9K
Earning Date
10-09-2026
10-21-2026
Dividend Yield
N/A
★ 13.46%
EPS Growth
N/A
★ N/A
EPS
0.23
★ 0.32
Revenue
★ $25,384,279.00
$8,666,307.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.43
★ $10.16
Revenue Growth
★ 9.76
N/A
52 Week Low
$2.72
$3.19
52 Week High
$5.45
$5.01

Technical Indicators

Market Signals
Indicator
CCEL
LOAN
Relative Strength Index (RSI) 51.48 29.12
Support Level $3.05 N/A
Resistance Level $5.45 $4.50
Average True Range (ATR) 0.34 0.09
MACD -0.02 -0.00
Stochastic Oscillator 48.21 6.45

Price Performance

Historical Comparison
CCEL
LOAN

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: